CN111491634A - 有机磷酸酯衍生物 - Google Patents
有机磷酸酯衍生物 Download PDFInfo
- Publication number
- CN111491634A CN111491634A CN201880063984.4A CN201880063984A CN111491634A CN 111491634 A CN111491634 A CN 111491634A CN 201880063984 A CN201880063984 A CN 201880063984A CN 111491634 A CN111491634 A CN 111491634A
- Authority
- CN
- China
- Prior art keywords
- compound
- pharmaceutically acceptable
- acceptable salt
- alkyl
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
- C07F9/6574—Esters of oxyacids of phosphorus
- C07F9/65742—Esters of oxyacids of phosphorus non-condensed with carbocyclic rings or heterocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
- C07F9/6574—Esters of oxyacids of phosphorus
- C07F9/65744—Esters of oxyacids of phosphorus condensed with carbocyclic or heterocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
- C07H19/11—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids containing cyclic phosphate
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762538879P | 2017-07-31 | 2017-07-31 | |
| US62/538,879 | 2017-07-31 | ||
| US201862637960P | 2018-03-02 | 2018-03-02 | |
| US62/637,960 | 2018-03-02 | ||
| PCT/US2018/044389 WO2019027905A1 (en) | 2017-07-31 | 2018-07-30 | ORGANOPHOSPHATE DERIVATIVES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111491634A true CN111491634A (zh) | 2020-08-04 |
Family
ID=65234161
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201880063984.4A Pending CN111491634A (zh) | 2017-07-31 | 2018-07-30 | 有机磷酸酯衍生物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11306111B2 (enExample) |
| EP (1) | EP3661513A4 (enExample) |
| JP (1) | JP2020529994A (enExample) |
| CN (1) | CN111491634A (enExample) |
| AU (1) | AU2018312224A1 (enExample) |
| CA (1) | CA3071612A1 (enExample) |
| WO (1) | WO2019027905A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018312224A1 (en) | 2017-07-31 | 2020-02-27 | January Therapeutics, Inc. | Organophosphate derivatives |
| EP3752511A4 (en) | 2018-01-10 | 2021-12-29 | Nucorion Pharmaceuticals, Inc. | Phosphor(n)amidatacetal and phosph(on)atalcetal compounds |
| US11427550B2 (en) | 2018-01-19 | 2022-08-30 | Nucorion Pharmaceuticals, Inc. | 5-fluorouracil compounds |
| AU2019227986A1 (en) * | 2018-03-02 | 2020-10-08 | January Therapeutics, Inc. | Nanoparticle compositions |
| CN112638927A (zh) * | 2018-08-20 | 2021-04-09 | 治愈生物医药公司 | 吉西他滨前药 |
| US20220220145A1 (en) * | 2019-04-22 | 2022-07-14 | Ligand Pharmaceuticals, Inc. | Cyclic phosphate compounds |
| GR1009958B (el) * | 2019-04-24 | 2021-03-18 | ΕΝΟΡΑΣΙΣ ΑΝΩΝΥΜΗ ΕΜΠΟΡΙΚΗ ΕΤΑΙΡΕΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ ΚΑΙ ΙΑΤΡΙΚΩΝ ΥΛΙΚΩΝ ΚΑΙ ΜΗΧΑΝΗΜΑΤΩΝ με δ.τ. "ΕΝΟΡΑΣΙΣ Α.Ε." | Παραγωγα γεμσιταβινης και μεθοδοι δημιουργιας παραγωγων γεμσιταβινης |
| EP3999519A4 (en) | 2019-07-17 | 2023-08-16 | Nucorion Pharmaceuticals, Inc. | CYCLIC DEOXYRIBONUCLEOTIDE COMPOUNDS |
| US11708637B2 (en) | 2019-08-13 | 2023-07-25 | The Regents Of The University Of California | Methods of supporting a graphene sheet disposed on a frame support |
| US12349192B2 (en) * | 2019-09-10 | 2025-07-01 | Sony Group Corporation | Wireless communication device and method |
| WO2021216427A1 (en) | 2020-04-21 | 2021-10-28 | Ligand Pharmaceuticals, Inc. | Nucleotide prodrug compounds |
| JP7559223B2 (ja) | 2020-08-24 | 2024-10-01 | ギリアード サイエンシーズ， インコーポレイテッド | リン脂質化合物及びその使用 |
| TW202344257A (zh) | 2020-10-16 | 2023-11-16 | 美商基利科學股份有限公司 | 磷脂化合物及其用途 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105979951A (zh) * | 2014-02-06 | 2016-09-28 | 里博科学有限责任公司 | 作为流感rna复制的抑制剂的4’-二氟甲基取代的核苷衍生物 |
| WO2016188943A1 (en) * | 2015-05-27 | 2016-12-01 | Idenix Pharmaceuticals Llc | Nucleotides for the treatment of cancer |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2874016B1 (fr) | 2004-06-30 | 2006-11-24 | Centre Nat Rech Scient Cnrse | Nanoparticules de derives de la gemcitabine |
| AU2006279720A1 (en) | 2005-08-12 | 2007-02-22 | Merck & Co., Inc. | Novel 2'-C-methyl and 4'-C-methyl nucleoside derivatives |
| WO2009126401A1 (en) | 2008-04-10 | 2009-10-15 | Abraxis Bioscience, Llc | Compositions of hydrophobic taxane derivatives and uses thereof |
| CN101732258B (zh) | 2008-11-19 | 2013-12-25 | 复旦大学附属华山医院 | 一种用于肿瘤化疗的纳米微球制剂及其制备方法 |
| GB201016855D0 (en) * | 2010-10-06 | 2010-11-17 | Nucana Biomed Ltd | Chemical compounds |
| KR20240119180A (ko) | 2011-01-24 | 2024-08-06 | 안테리오스, 인코퍼레이티드 | 나노입자 조성물, 이의 제형, 및 그의 용도 |
| US20130131008A1 (en) | 2011-10-25 | 2013-05-23 | Board Of Regents, The University Of Texas System | Lipophilic monophosphorylated derivatives and nanoparticles |
| SI2794627T1 (sl) | 2011-12-22 | 2019-02-28 | Alios Biopharma, Inc. | Substituirani nukleozidi, nukleotidi in njihovi analogi |
| CN103239733A (zh) | 2012-02-09 | 2013-08-14 | 复旦大学附属肿瘤医院 | 一种整合素靶向型载药白蛋白纳米粒制剂及其制备方法 |
| AR092959A1 (es) | 2012-10-17 | 2015-05-06 | Merck Sharp & Dohme | Derivados de nucleosidos 2-metil sustituidos y metodos de uso de los mismos para el tratamiento de enfermedades virales |
| US20140199404A1 (en) | 2013-01-11 | 2014-07-17 | Abraxis Bioscience, Llc | Method for treating cancer based on level of a nucleoside transporter |
| EP4378461A3 (en) | 2013-03-05 | 2024-09-11 | The Regents of University of California | Lipid bilayer coated mesoporous silica nanoparticles with a high loading capacity for one or more anticancer agents |
| US8889701B1 (en) * | 2013-10-11 | 2014-11-18 | Alla Chem, Llc | Substituted (S)-(2R,3R,5R)-3-hydroxy-(5-pyrimidin-1-yl)tetrahydrofuran-2-ylmethyl aryl phosphoramidate |
| JP6562908B2 (ja) * | 2013-10-11 | 2019-08-21 | ヤンセン バイオファーマ インク． | 置換ヌクレオシド、置換ヌクレオチドおよびその類似体 |
| KR20150047336A (ko) | 2013-10-24 | 2015-05-04 | 삼성전자주식회사 | 나노입자, 이를 제조하는 방법, 및 이의 용도 |
| WO2015134334A1 (en) * | 2014-03-03 | 2015-09-11 | Suo Zucai | Gemcitabine analogs |
| AU2015280248B2 (en) | 2014-06-24 | 2021-04-08 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| TWI678373B (zh) | 2014-10-31 | 2019-12-01 | 日商富士軟片股份有限公司 | 硫代核苷衍生物或其鹽及醫藥組合物 |
| CN104961786B (zh) | 2015-06-05 | 2018-09-25 | 苏州大学 | 基于吉西他滨结构的前体药物及其应用 |
| KR102408525B1 (ko) | 2016-01-08 | 2022-06-13 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | 화물 전달용 지질 2중층 코팅물을 가진 메조다공성 실리카 나노입자 |
| AU2018312224A1 (en) | 2017-07-31 | 2020-02-27 | January Therapeutics, Inc. | Organophosphate derivatives |
| AU2019227986A1 (en) | 2018-03-02 | 2020-10-08 | January Therapeutics, Inc. | Nanoparticle compositions |
| EP3758490A4 (en) | 2018-03-02 | 2021-12-22 | January Therapeutics, Inc. | COMPOSITIONS OF NANOPARTICLES |
| WO2020041051A1 (en) | 2018-08-20 | 2020-02-27 | Cure Biopharma Inc. | Gemcitabine prodrugs |
| CN112638927A (zh) | 2018-08-20 | 2021-04-09 | 治愈生物医药公司 | 吉西他滨前药 |
| WO2020223530A1 (en) | 2019-04-30 | 2020-11-05 | Cure Biopharma Inc. | Gemcitabine prodrugs |
| US11708637B2 (en) | 2019-08-13 | 2023-07-25 | The Regents Of The University Of California | Methods of supporting a graphene sheet disposed on a frame support |
-
2018
- 2018-07-30 AU AU2018312224A patent/AU2018312224A1/en not_active Abandoned
- 2018-07-30 CA CA3071612A patent/CA3071612A1/en active Pending
- 2018-07-30 US US16/635,469 patent/US11306111B2/en active Active
- 2018-07-30 EP EP18840263.0A patent/EP3661513A4/en not_active Withdrawn
- 2018-07-30 CN CN201880063984.4A patent/CN111491634A/zh active Pending
- 2018-07-30 WO PCT/US2018/044389 patent/WO2019027905A1/en not_active Ceased
- 2018-07-30 JP JP2020505363A patent/JP2020529994A/ja active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105979951A (zh) * | 2014-02-06 | 2016-09-28 | 里博科学有限责任公司 | 作为流感rna复制的抑制剂的4’-二氟甲基取代的核苷衍生物 |
| WO2016188943A1 (en) * | 2015-05-27 | 2016-12-01 | Idenix Pharmaceuticals Llc | Nucleotides for the treatment of cancer |
Non-Patent Citations (1)
| Title |
|---|
| 姬勋等: "磷酸酯前药在药物研究中的应用", 《药学学报》 * |
Also Published As
| Publication number | Publication date |
|---|---|
| US11306111B2 (en) | 2022-04-19 |
| JP2020529994A (ja) | 2020-10-15 |
| CA3071612A1 (en) | 2019-02-07 |
| WO2019027905A1 (en) | 2019-02-07 |
| AU2018312224A1 (en) | 2020-02-27 |
| EP3661513A4 (en) | 2021-07-14 |
| EP3661513A1 (en) | 2020-06-10 |
| US20200369695A1 (en) | 2020-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111491634A (zh) | 有机磷酸酯衍生物 | |
| ES2974494T3 (es) | Compuestos tricíclicos fusionados de piridazinona útiles para tratar las infecciones por ortomixovirus | |
| TWI406864B (zh) | 化合物 | |
| JP7222590B2 (ja) | ３－アザビシクロ［３，１，１］ヘプタン誘導体及びこれを含む薬学的組成物 | |
| KR101982951B1 (ko) | 신규한 유형의 시티딘 유도체 및 그의 용도 | |
| JP6966425B2 (ja) | 抗がん剤としての複素環式の限定された三環系スルホンアミド | |
| CN113444144A (zh) | 一种蛋白酶抑制剂及其药物组合物和用途 | |
| TW202220963A (zh) | 化合物、組合物及方法 | |
| WO2013033093A1 (en) | Heterocyclic compounds as janus kinase inhibitors | |
| US12071441B2 (en) | 10-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1′,2′:4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenza | |
| JP4291688B2 (ja) | Ｃｏｘ−２選択的阻害剤として有用なピリミジン誘導体 | |
| WO2019042442A1 (zh) | 一类具有抑制并降解酪氨酸蛋白激酶jak1或jak2活性的化合物 | |
| CN111918870B (zh) | 氘代的低聚核苷酸及前体药物 | |
| CN120712260A (zh) | 含有二氢酞嗪和烯基的化合物及其用途 | |
| TWI652265B (zh) | 氮雜吲哚衍生物 | |
| CN112105355A (zh) | Abhd12抑制剂及其制造和使用方法 | |
| WO2019080724A1 (zh) | 核苷磷酸类化合物及其制备方法和用途 | |
| HK40035089A (en) | Organophosphate derivatives | |
| TWI716427B (zh) | 吡咯并[2,3-d]嘧啶化合物或其鹽 | |
| HK40033744B (zh) | 作为正粘病毒复制抑制剂用於治疗流感的化合物 | |
| HK40119293A (en) | Fused tricyclic pyridazinone compounds and prodrugs thereof useful to treat orthomyxovirus infections | |
| BR122023025728A2 (pt) | Derivados de 10-(di(fenil)metil)-4-hidróxi-8,9,9a-10-tetra-hidro-7hpirrolo[1',2':4,5]pirazino[1,2-b]piridazina-3,5-diona e compostos relacionados como inibidores de da replicação de ortomixovírus, seus usos para tratamento de influenza, composição farmacêutica, e combinação | |
| HK40033744A (en) | Compounds as inhibitors of the orthomyxovirus replication for treating influenza |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40035089 Country of ref document: HK |
|
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200804 |